STAND. COM. REP. NO. 1810_______

                                 Honolulu, Hawaii
                                                   , 1999

                                 RE: S.B. No. 1160
                                     S.D. 2
                                     H.D. 2




Honorable Calvin K.Y. Say
Speaker, House of Representatives
Twentieth State Legislature
Regular Session of 1999
State of Hawaii

Sir:

     Your Committee on Finance, to which was referred S.B. No.
1160, S.D. 2, H.D. 1, entitled: 

     "A BILL FOR AN ACT RELATING TO CONTROLLED SUBSTANCES,"

begs leave to report as follows:

     The purpose of this bill is to amend the Uniform Controlled
Substances Act to:

     (1)  Conform to changes in federal and state law;

     (2)  Add a new definition for the term "ephedrine";

     (3)  Update the record-keeping requirement for controlled
          substances to five years;

     (4)  Standardize the controlled substances prescription
          sizes;

     (5)  Expand the list of chemicals subject to mandatory
          reporting requirements;

     (6)  Prevent the unauthorized use of Drug Enforcement Agency
          hospital numbers and internal codes;

     (7)  Establish penalties for sellers of ephedrine products
          who make claims that consumption of such products will
          produce effects of ecstasy, euphoria, increased sexual

 
 
                                 STAND. COM. REP. NO. 1810_______
                                 Page 2

 
          sensations, heightened awareness, increased energy,
          legal "highs", or other similar effects;
     (8)  Increase the penalties for the sale or distribution of
          a regulated chemical without a permit or by a person
          convicted for the second time of a permit violation;

     (9)  Clarify that information communicated to a physician in
          an effort to unlawfully procure a controlled substance
          is not a privileged communication; and

     (10) Clarify that reporting requirements do not apply to
          manufacturers, wholesalers, retailers, or other persons
          who sell or transfer into the State any over-the-
          counter drug product containing pseudoephedrine,
          norpseudoephedrine, phenylpropanolamine, or any
          ephedrine combination products below the cumulative
          threshold of one kilogram.

     The Department of Public Safety, Longs Drug Stores, and the
Dietary Supplement Safety and Science Coalition testified in
support of this measure.  The Honolulu Police Department
testified in support of the intent of this measure.  The
Legislative Information Services of Hawaii commented on this
measure.

     Your Committee has amended this bill by making technical,
nonsubstantive amendments for clarity and style.

     As affirmed by the record of votes of the members of your
Committee on Finance that is attached to this report, your
Committee is in accord with the intent and purpose of S.B. No.
1160, S.D. 2, H.D. 1, as amended herein, and recommends that it
pass Third Reading in the form attached hereto as S.B. No. 1160,
S.D. 2, H.D. 2.

                                   Respectfully submitted on
                                   behalf of the members of the
                                   Committee on Finance,



                                   ______________________________
                                   DWIGHT Y. TAKAMINE, Chair